Bone marrow transplantation - A new treatment option in severe SLE?;KNOCHENMARKTRANSPLANTATION - EINE NEUE OPTION BEI SCHWEREM SLE?

Aktuelle Rheumatologie

Volumn 21, Issue 2, 1996, Pages 114-122

  Euler, H H ^a   Fastenrath, S ^a   Dreger, P ^a   Schmitz, N ^a   Marmont, A ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE;

AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; DRUG THERAPY; HUMAN; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY;

EID: 0029884930     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043696     Document Type: Review

References (92)

1. Abu-Shakra, M., M. B. Urowitz, D. D. Gladman, J. Gough: Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J. Rheumatol. 22 (1995) 1259-1264
2. Aldouri, M. A., R. Ruggier, O. Epstein, H. G. Prentice: Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. Br. J. Haematol. 74 (1990) 118-119
3. Atkinson, J. P.: Some thoughts on autoimmunity. Arthritis Rheum. 38 (1995) 301-305
4. Baldwin, J. L., R. Storb, E. D. Thomas, M. Mannik: Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum. 20 (1977) 1043-1048
5. Blank, M., I. Krause, N. Lanir, P. Vardi et al.: Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum. 38 (1995) 115-122
6. Blank, M., Y. Tomer, S. Slavin, Y. Shoenfeld: Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation. Scand. J. Immunol. 42 (1995) 226-234
7. Boumpas, D. T., H. A. Austin, E. M. Vaughn, J. H. Klippel et al.: Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340 (1992) 741-745
8. Boumpas, D. T., H. A. Austin, 3rd, B. J. Fessler, J. E. Balow, J. H. Klippel, M. D. Lockshin: Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann. Intern. Med. 122 (1995) 940-950
9. Boumpas, D. T., B. J. Fessier, H. A. Austin, 3rd, J. E. Balow, J. H. Klippel, M. D. Lockshin: Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann. Intern. Med. 123 (1995) 42-53
10. Brenner, M. K., D. R. Rill: Gene marking to improve the outcome of autologous bone marrow transplantation. J. Hematother. 3 (1994) 33-36
11. Brugger, W., S. Heimfeld, R. J. Berensson, R. Mertelsmann, L. Kanz: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med. 333 (1995) 283-287
12. Burt, P. K., W. Bums, A. Hess: Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplant. 16 (1995) 1-6
13. Dreger, P., P. Marquardt, T. Haferlach, S. Jacobs et al.: Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' und G-CSF: timing of harvesting and composition of the leukapheresis product. Br. J. Cancer 68 (1993) 950-957
14. Dreger, P., K. Viehmann, J. Steinmann, V. Eckstein et al.: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T cell depletion strategies using different CD34+ selection system of CAMPATH-1 Exp. Hematol. 23 (1995) 147-154
15. Elliott, M. J., R. N. Maini, M. Feldmann, J. R. Kalden et al.: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344 (1994) 1105-1110
16. Euler, H. H., J. O. Schroeder: Antibody depletion and cytotoxid drug therapy in severe systemic lupus erythematosus. Transfus. Sci. 13 (1992) 167-184
17. Euler, H. H., J. O. Schroeber, P. Harten, R. A. Zeuner, H. J. Gutschmidt: Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum. 37 (1994) 1784-1794
18. Fastenrath, S., P. Dreger, N. Schmitz, H. H. Euler: Autologous unpurged bone marrow transplantation in a patient with lymphoma and SLE: short term recurrence of antinuclear antibodies. Arthritis Rheum. 38 (Suppl.) (1995) S303 (Abstract)
19. Fefer, A.: Graft-versus-tumor response: Adoptive cellular therapy in bone marrow transplantation. In: Bone marrow transplantation, (eds.): Forermann, S. J., K. G. Blume, E. D. Thomas: Blackwell scientific Publications, Boston (1993) 231-241
20. Freedman, A. S.: Cell surface markers in leukemia and lymphoma. In: Lymphocytes and granulocytes, (ed.): Harris, G. R.: Plenum Press, New York (1992) 33-71
21. Gassmann, W., L. Uharek, A. Erbersdobler, B. Glass et al.: High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential. Br. J. Haematol. 78 (1991) 310-318
22. Gassmann, W., L. Uharek, H. U. Wottge, N. Schmitz, H. Loeffler, W. Mueller-Ruchhooltz: Comparison of cyclophosphamidie, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation. Blood 72 (1988) 1574-1579
23. Georgiou, H. M., R. M. Slattery, B. Charlton: Bone marrow transplantation prevents autoimmune diabetes in nonobese diabetic mice. Transplant. Proc. 25 (1993) 2896-2897
24. Goldman, J.: Peripheral blood stem cells for allografting. Blood 85 (1995) 1413-1415
25. Graninger, W. B., W. Hassfeld, B. B. Pesau, K. P. Machold, C. C. Zielinski, J. S. Smolen: Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J. Rheumatol. 18 (1991) 1621-1622
26. Gribben, J. G., L. M. Nadler: Antibody-mediated purging. In: Bone marrow transplantation, (eds.): Foreman, S. J., K. G. Blume, E. D. Thomas: Blackwell Scientific Publications, Boston (1995) 149-163
27. Haylock, D. N., L. B. To, T. L. Dowse, C. A. Juttner, P. J. Simmons: Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 80 (1992) 1405-1412
28. Haynes, B. F., S. M. Denning: Lymphopoiesis. In: The molecular basis of blood diseases, (eds.): Stamatoyannopoulos, G. et al.: Saunders, Philadelphia (1993) 238-248
29. Hiepe, F., H. D. Volk, E. Apostoloff, R. v. Baehr: Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody. Lancet 338 (1991) 1529-1530
30. Holland, F. J., J. K. McConnon, R. Volpe, E. F. Saunders: Concordant Graves' disease after bone marrow transplantation: implications for pathogenesis. J. Clin. Endocrinol. Metab. 72 (1991) 837-840
31. Horneff, G., G. R. Burmester, F. Emmrich, J. R. Kalden: Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum. 34 (1991) 129-140
32. Horowitz, M. M., R. P. Gale: Graft-versus-leukemia. In: New strategies in bone marrow transplantation, (eds.): Champlin, R. E., R. P. Gale: Wiley-Liss, New York (1990) 275-280
33. Ikehara, S.: Intractable diseases and bone marrow transplantation. Pathol. Int. 44 (1994) 817-826
34. Ikehara, S., M. Kawamura, F. Takao, M. Inaba et al.: Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 87 (1990) 8341-8344
35. Ikuta, K., N. Uchida, J. Friedman, I. L. Weissman: Lymphocyte development from stem cells. Annu. Rev. Immunol. 10 (1992) 759-783
36. Jacobs, P., M. D. Vincent, R. W. Martell: Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant. 1 (1986) 237-239
37. Karussis, D. M., S. Slavin, A. Ben-Nun, H. Ovadia et al.: Chronic-relapsing experimental autoimmune encephalomyelitis (CREAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation. J. Neuroimmunol. 39 (1992) 201-210
38. Karussis, D. M., U. Vourka-Karussis, D. Lehmann, O. Abramsky, A. Ben-Nun, S. Slavin: Immunomodulation of autoimmunity in MRL/Ipr mice with syngeneic bone marrow transplantation (SBMT). Clin. Exp. Immunol. 100 (1995) 111-117
39. Karussis, D. M., U. Vourka-Karussis, D. Lehmann, H. Ovadia et al.: Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. J. Clin. Invest. 92 (1993) 765-772
40. Kernan, N. A.: T-cell depletion for prevention of graft-versus-host disease. In: Bone marrow transplantation, 8eds.): Foreman, S. J., K. G. Blume, E. D. Thomas: Blackwell Scientific Publications, Boston (1993) 124-135
41. Knaan-Shanzer, S., P. Hoben, E. P. Kinwel-Bohre, D. W. van Bekkum: Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant. 8 (1991) 333-338
42. Kogler, G., H. H. Wolf, A. Heyll, G. Arkesteijn, P. Wernet: Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells. Bone Marrow Transplant. 15 (1995) 41-48
43. LaFace, D. M., A. B. Peck: Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes 38 (1989) 894-901
44. Lampeter, E. F., M. Hornberg, K. Quabeck, U. W. Schaefer et al.: Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341 (1993) 1243-1244
45. Leiter, E. H., D. V. Serreze: Autoimmune diabetes in the nonobese diabetic mouse: suppression of immune defects by bone marrow transplantation and implications for therapy. Clin. Immunol. Immunopathol. 59 (1991) 323-334
46. Levite, M., H. Zinger, E. Mozes, Y. Reisner: Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells. Bone Marrow Transplant. 12 (1993) 179-183
47. Levite, M., H. Zinger, E. Zisman, Y. Reisner, E. Mozes: Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus. Cell Immunol. 162 (1995) 138-145
48. Lin, H.: Differential lethal effect of cytotoxic agents on proliferating and nonprotiferating lymphoid cells. Cancer Res. 33 (1973) 1716
49. Lowenthal, R. M., M. L. Cohen, K. Atkinson, J. C. Biggs: Apparent cure of rheumatoid arthritis by bone arrow transplantation. J. Rheumatol. 20 (1993) 137-140
50. Marmont, A., A. Tyndall, A. Gratwohl, T. Vischer: Haemopoietic precursor-cell transplants for autoimmune diseases. Lancet 345 (1995) 978
51. Marmont, A. M.: Immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus? Lupus 2 (1993) 151-156
52. Marmont, A. M.: Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases? Stem. Cells (Dayt). 12 (1994) 125-135
53. Marmont, A. M., D. W. van Bekkum: Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions. Bone Marrow Transplant. 16 (1995) 497-498
54. Minchinton, R. M., A. H. Waters, J. Kendra, A. J. Barrett: Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft. Lancet 2 (1982) 627-629
55. Morton, J. I., B. V. Siegel: Transplantation of autoimmune potential. IV. Reversal of the NZB autoimmune syndrome by bone marrow transplantation. Transplantation 27 (1979) 133-134
56. Morton, J. I., B. V. Siegel, R. D. Moore: Transplantation of autoimmune potential. II. Glomerulonephritis in lethally irradiated DBA/2 recipients of NZB bone marrow cells. Transplantation 19 (1975) 464-469
57. Neuwelt, C. M., S. Lacks, B. R. Kaye, J. B. Ellman, D. G. Borenstein: Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am. J. Med. 98 (1995) 32-41
58. Pestronk, A., D. B. Drachman, R. Teoh, R. N. Adams: Combined short-term immunotherapy for experimental autoimmune myasthenia gravis. Ann. Neurol. 14 (1983) 235-241
59. Petit, T., B. Raynal, G. Socie, J. Landman-Parker et al.: Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-cepleted bone marrow transplantation. Blood 84 (1994) 3575-3583
60. Roberts, M. M., L. B. To, D. Gillis, J. Mundy et al.: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant. 12 (1993) 469-475
61. Ronnblom, L. E., G. V. Alm, K. E. Oberg: Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J. Intern. Med. 227 (1990) 207-210
62. Ruiz, P. J., H. Zinger, E. Mozes: Induction ofexperimental systemic lupus erythematosus in mice by immunization with the F(ab')2 fragment of the human anti-DNA monoclonal antibody carrying the 16/6 idiotype. Immunol. Lett. 41 (1994) 79-84
63. Salzman, D., J. Tami, C. Jackson et al.: Clinical remission of myasthenia gravis in a patient after high dose therapy and autologous transplantation with CD34+ stem cells. Blood 84 (suppl. 1) (1994) 206a (Abstract)
64. Schmitz, N., P. Dreger, M. Suttorp, E. B. Rohwedder et al.: Primary transplantation of allogeneic peripheral blood progenitor cells mobilizied by filgrastim (granulocyte colonystimulating factor). Blood 85 (1995) 1666-1672
65. Schroeder, J. O., H. H. Euler, H. Loeffler. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann. Intern. Med. 107 (1987) 344-346
66. Sheridan, W. P., C. G. Begley, C. A. Juttner, J. Szer et al.: Effect of peripheral-blood progenitor cells mobilised by filgrastim (GCSF) on platelet recovery after high-dose chemotherapy. Lancet 339 (1992) 640-644
67. Shoenfeld, Y., E. Mozes: Pathogenic anti-DNA idiotype (16/6 Id) in systemic lupus erythematosus. Rheumatol. Int. 11 (1991) 91-93
68. Shpall, E. J., R. B. Jones, S. I. Bearman, W. A. Franklin et al.: Transplantation of enriched CD34-positive autologous marrow into breat cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12 (1994) 28-36
69. Slavin, S., D. Karussis, L. Weiss, U. Vourka-Karussis, O. Abramsky: immunohematopoietic reoncstitution by allogeneic and uatologous bone marrow grafats as a means for induction of specific unresponsiveness to donor-specfici allografts and modified self in autoimmune disorders. Transplant. Proc. 25 (1993) 1274-1275
70. Sobocinski, K. A., M. M. Horowitz, P. A. Rowlings, M. J. Zhang et al.: Bone marrow transplantation - 1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. J. Hematother. 3 (1994) 95-102
71. Storek, J., L. King, S. Ferrara, D. Marcelo, A. Saxon, J. Braun: Abundance of a restrictred fetal B cell repertoire in marrow transplant recipients. Bone Marrow Transplant. 14 (1994) 783-790
72. Sullivan, K. M., H. J. Deeg, J. E. Sanders, H. M. Shulman et al.: Late complications after marrow transplantation. Semin. Hematol. 21 (1984) 53-63
73. Suttorp, M., C. Sprenger, P. Dreger, E. Sievers et al.: Amplificatino of a Y-chromosomal DNA sequence by the polymerase chain reaction for documentation of residual recipient cells in small samples from bone marrow, peripheral blood and cerebrospinal fluid after bone marrow transplantation. Electrophoresis 14 (1993) 174-178
74. Than, S., H. Ishida, M. Inaba, Y. Fukuba et al.: Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J. Exp. Med. 176 (1992) 1233-1238
75. Theofilopoulos, A. N.: The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol. Today 16 (1995) 90-98
76. Theofilopoulos, A. N.: The basis of autoimmunity: part II. Genetic predisposition. Immunol. Today 16 (1995) 150-159
77. Treleaven, J., J. Barrett: Bone marrow transplantation in practice. Churchill Livingston, Edinburgh (1992)
78. Uharek, L., W. Gassmann, D. Fleischhauer, H. U. Wottge, H. Loeffler, W. Mueller-Ruchholtz: Effect of post-transplant methotrexate, cyclosporin A and prednisolone on graft rejection after allogeneic bone marrow transplantation. Bone Marrow Transplant. 7 (1991) 17-22
79. Uharek, L., B. Glass, T. Gaska, W. Gassmann, H. Loeffler, W. Mueller-Ruchholzt: Influence of donor lymphocytes on the incidence of primary graft failure after allogeneic bone marrow transplantation in a murine model. Br. J. Haematol. 88 (1994) 79-87
80. van Bekkum, D. W.: BMT in experimental autoimmune diseases. Bone Marrow Transplant. 11 (1993) 183-187
81. van Bekkum, D. W., E. P. Bohre, P. F. Houben, S. Knaan-Shanzer: Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc. Natl. Acad. Sci. USA 86 (1989) 10090-10094
82. van der Lubbe, P. A., B. A. Dijkmans, H. M. Markusse, U. Nassander, F. C. Breedveld: A randomized, double-blind, placebo-con-trolled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis & Rheumatism. 38 (1995) 1097-1106
83. van Gelder, M., E. P. Kinwel-Bohre, D. W. van Bekkum: Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT, Bone Marrow Transplant. 11 (1993) 233-241
84. Verdonck, L. F., W. L. van Putten, A. Hagenbeek, H. C. Schouten et al.: Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N. Engl. J. Med. 332 (1995) 1045-1051
85. Vialettes, B., D. Maraninchi, M. P. San Marco, F. Birg et al.: Autoimmune polyendocrine failure - type 1 (insulin-dependent) diabetes mellitus and hypothyroidism - after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia. Diabetologic 36 (1993) 541-546
86. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch et al.: Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333 (1995) 1038-1044
87. Ward, M. M., E. Pyun, S. Studenski: Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcome. Arthritis Rheum. 38, 1995) 274-283
88. Weisdorf, D., R. Hakke, B. Blazar, W. Miller et al.: Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51 (1991) 1197-1203
89. West, S. G., W. Emlen, M. H. Wener, B. L. Kotzin: Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am. J. Med. 99 (1995) 153-163
90. Wyatt, D. T., L. G. Lum, J. Casper, J. Hunter, B. Camitta: Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant 5 (1990) 357-361
91. Yin, J. A., S. N. Jowitt: Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant. 9 (1992) 31-33
92. Zeis, M., L. Uharek, B. Glass, T. Gaska et al.: Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice. Transplantation 59 (1995) 1734-1736